Status:
UNKNOWN
Validity of Mediastinal Blood Pool SUV Ratio
Lead Sponsor:
Assiut University
Conditions:
Validity of Blood Pool SUV Ratio in Identification of Malignancy in Case of Diseased Liver
Eligibility:
All Genders
Brief Summary
-Validity of blood pool SUV ratio in identification of malignancy in case of diseased liver.
Detailed Description
PET/CT is the functional imaging tool that can measure increased glucose metabolism in cancer tissues by using flourine 18 FDG which is FDA approved and used routinely in identification of malignant l...
Eligibility Criteria
Inclusion
- This study will include cancer pt who did PET/CT scan who presented to nuclear medicine unit during the period from 2021 until the end of the study.
Exclusion
- Severely ill patient
- Pt with glucose level above 200
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT05258045
Start Date
June 1 2022
End Date
December 30 2023
Last Update
February 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.